Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03013218
Title A Study of ALX148 in Patients With Advanced Solid Tumors and Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Alexo Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado Denver Denver Colorado 80045 United States Details
Yale University New Haven Connecticut 06520 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
START-Midwest Grand Rapids Michigan 49503 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
Seoul National University Bundang Hospital Seongnam Korea, Republic of Details
Samsung Medical Center Seoul Korea, Republic of Details
Seoul National University Hospital Seoul Korea, Republic of Details
Severance Hospital, Yonsei University Seoul Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field